A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/202 (2006.01) A61K 31/232 (2006.01) A61P 25/00 (2006.01)
Patent
CA 2499142
Eicsapentaenoic acid (EPA) is used in the treatment of anorexia nervosa, bulimia and related clinical syndromes.
L'invention a trait à une méthode faisant appel à l'acide eicosapentanoïque (EPA) pour traiter l'anorexie nerveuse, la boulimie et les syndromes cliniques apparentés.
Ayton Agnes
Horrobin David Frederick
Fetherstonhaugh & Co.
Laxdale Limited
LandOfFree
Eicosapentaenoic acid (epa) for treating anorexia nervosa... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Eicosapentaenoic acid (epa) for treating anorexia nervosa..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Eicosapentaenoic acid (epa) for treating anorexia nervosa... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1884387